Caverject Impulse (U.S. Pharmaceuticals)


Welcome to the PulseAid listing for the Caverject Impulse drug offered from U.S. Pharmaceuticals. This Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: U.S. Pharmaceuticals
NON-PROPRIETARY NAME: Alprostadil
SUBSTANCE NAME: ALPROSTADIL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE]
ROUTE: INTRACAVERNOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2014-05-04
END MARKETING DATE: 0000-00-00


Caverject Impulse HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCaverject Impulse from U.S. Pharmaceuticals
LABELER NAME: U.S. Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 10(ug/.5mL)
START MARKETING DATE: 2014-05-04
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63539-121_0dcd3231-552e-4243-bbc9-b8ed733d3ff4
PRODUCT NDC: 63539-121
APPLICATION NUMBER: NDA021212

Other ALPROSTADIL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actient Pharmaceuticals, LLCEdex
Meda PharmaceuticalsMUSE
Pharmacia and Upjohn Company LLCPROSTIN
Teva Parenteral Medicines, Inc.Alprostadil
U.S. PharmaceuticalsCaverject Impulse